Abstract
Sterotactic radiosurgery (SRS) is an effective and commonly employed therapy for metastatic brain tumors. Among complication of this treatment, symptomatic focal cerebral radionecrosis (RN) occurs in 2–10 % of cases. The large diffusion of combined therapies as SRS followed by WBRT and/or CHT, has significantly amplified the number of patients who potentially might be affected by this pathology and neurosurgeons are increasingly called to treat suspected area of RN. Results of surgery of RN in patients with brain metastases are rarely reported in literature, a standardization of diagnostic work-up to correctly identify RN is still lacking and the timing and indications in favour of surgical therapy over medical treatments are not clear as well. In this retrospective study, we review current concept related to RN and analyze the outcome of surgical treatment in a series of 15 patients previously submitted to SRS for brain metastases and affected by suspected radionecrotic lesions. After surgery, all patients except one neurologically improved. No intra-operative complications occurred. Brain edema improved in all patients allowing a reduction or even suspension of corticosteroid therapy. Pure RN was histologically determined in 7 cases; RN and tumor recurrence in the other 8. Overall median survival was 19 months. An aggressive surgical attitude may be advisable in symptomatic patients with suspected cerebral RN, to have histologic confirmation of the lesion, to obtain a long-lasting relief from the mass effect and brain edema and to improve the overall quality of life, sparing a prolonged corticosteroid therapy.
Similar content being viewed by others
References
Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75(1):5–14
Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491
Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 22:97–104
Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, Fuhrer R (2009) Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 27(6):E7
Mut M (2012) Surgical treatment of brain metastases: a review. Clin Neurol Neurosurg 114(1):1–8
Kano H, Kondziolka D, Zorro O, Lobato-Polo J, Flickinger JC, Lunsford LD (2009) The results of resection after stereotactic radiosurgery for brain metastases. J Neurosurg 111:825–831
Petrovich Z, Yu C, Giannotta SL, O’Day S, Apuzzo MLJ (2002) Survival pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 97(Suppl 5):499–506
Vidiri A, Guerrisi A, Pinzi V, Fabi A, Mirri MA, Pompili A, Caporale N, Pace A, Crecco M, Marzi S (2012) Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis? Eur J Radiol 81(6):1246–1252
Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Maurizi Enrici R (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 15(6):48
Friso WA, Hoefnagels FJ, Lagerwaard E, Sanchez E, Haasbeek CJA, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of brain metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887
Maldaun MVC, Aguiar PHP, Land F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatmeny of brain mestastases: critical review regarding complications. Neurosurg Rev 31:1–9
Shöggl A, Kitz K, Reddy M, Wolfsberger St, Schneider B, Dieckmann K, Ungersböck (2000) Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 142:621–626
Yang H, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D (2011) What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery 68:682–690
Kalkanis SN, Kondziolka D, Gaspar IF, Burri SH, Asher AL, Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Lynskey ME (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systemic review and evidence-based clinical practice guideline. J Neurooncol 96:33–43
Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? Neurosurgery 63:898–904
Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P (2006) Cerebral radiation necrosis: incidence, outcomes, and risk fctors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65:499–508
Carangelo B, Cerillo A, Mariottini A, Peri G, Rubino G, Mourmouras V, Palma L, Antenore S (2010) Therapeutic strategy of late cerebral radionecrosis: a retrospective study of 21 cases. J Neurosurg Sci 54:21–28
Wong ST, Loo KT, Yam KY, Hung WM, Fok KF, Yuen SC, Fong D (2010) Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma. J Neurosurg 113:293–300
Giglio P, Gilbert MR (2003) Cerebral radiation necrosis. Neurologist 9(4):180–188
Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as predictor of brain radiosurgery after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77(4):996–1001
Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 17:243–252
Dropcho EJ (2010) Neurotoxicity of radiation therapy. Neurol Clin 28:217–234
Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94(1):63–68
Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC, Knopp EA, Han K, Golfinos JG (2006) Results of surgical resection for progression of brain metastases previously treated by gamma-knife radiosurgery. Neurosurgery 59:86–97
Williams BJ, Suki D, Fox B, Pelloski CE, Maldaun MVC, Sawaya RE, Lang FF, Rao G (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439–448
Kjellberg RN (1979) Isoeffective dose parameters for brain necrosis in relation to proton radiosurgical dosimetry. In Szilka G (ed). Sterotactic cerebral irradiation. INSERM symposium, vol 12. Elsevier Press, Amsterdam, p 157–166
Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148
Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine W (2004) Stereotactic Radiosurgery of 468 brain metastases ≤ 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiation Oncol Biol Phys 59(1):87–93
Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141
Swinson BM, Friedman WA (2008) Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida. Neurosurgery 62:1018–1032
Stockham AL, Suh JH, Chao ST, Barnett GH (2012) Management of recurrent brain metastases after radiosurgery. Prog Neurol Surg 25:273–285
Safdari H, Fuentes JM, Dubois JB, Alirezai M, Castan P, Vlahovitch B (1985) Radiation necrosis of the brain: time of onset and incidence related to a total dose and fractionation of radiation. Neuroradiology 27:44–47
Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH (1995) Reoperation for recurrent metastatic brain tumors. J Neurosurg 83:600–604
Molenaar R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C (2009) Relationship between volume, dose, and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23(2):170–178
Foroughi M, Kemeny Lehecka M, Wons J, Kajidi L, Hatfield R, Marks S (2010) Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations-case analysis and literature review. Acta Neurochir 152:803–815
Vecil GG, Suki D, Muldaun MV, Lang FF, Sawaya R (2005) Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg 102:209–215
Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424
Ohtakara K, Hayashi S, Nakayama N, Ohe N, Yano H, Iwama T, Hoshi H (2012) Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after multileaf collimator-based stereotactic radiosurgery for brain metastases. J Neurooncol 108:201–209
Szeifert GT, Massager N, DeVriendt D, David D, De Smedt F, Rorive Salmon I, Brotchi J, Levivier M (2002) Observations of intracranial neoplasms treated with gamma knife radiosurgery. J Neurosurg 97:623–626
Coderre JA, Morris GM, Micca PL, Hopewell JW, Verhagen I, Kleiboer BJ, van der Kogel AJ (2006) Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survivor. Radiat Res 166:495–503
Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR 30:367–372
Sundgren PC (2009) MR spectroscopy in radiation injury. AJNR 30:1469–1476
Ross DA, Sandler HM, Balter JM et al (2002) Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175–182
Belohlavek O, Simonova G, Kantorova I, Novotny J Jr, Liscak R (2003) Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumor progression? Eur J Nucl Med Mol Imaging 30(1):96–100
Jain R, Narang J, Sundgren PM, Hearshen D, Saksena S, Rock JP, Gutierrez J, Mikkelsen (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29
Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323–326
Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDErmott M, Mehta MP, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systemic review and evidence-based clinical practice guidelines. J Neurooncol 96:85–96
Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47(4):1001–1006
Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearschen D, Babajani-Feremi A (2011) Differentiating treatment-induced radionecrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol 13(9):1037–1046
McPherson C, Warnick R (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68(1):41–47
Acknowledgments
The authors thank Mrs. Mariantonia Carosi MD (Department of Pathology, Istituto Nazionale Tumori “Regina Elena”) for her review of the histologic material, Mrs. Marzia Piccoli and Mrs. Maria Di Santo for the editorial and archives assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Telera, S., Fabi, A., Pace, A. et al. Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease. J Neurooncol 113, 313–325 (2013). https://doi.org/10.1007/s11060-013-1120-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-013-1120-8